Switch to:
More From Other Websites
Celgene says patent-fighting hedge fund manager wants to short its shares Jul 29 2015
Drugmakers Strike Back: Kyle Bass Blasted Over Patent Challenges Jul 29 2015
Q2 Earnings Season Halftime Report Jul 29 2015
Four Reasons Gilead Can Head Higher Jul 29 2015
Bristol-Myers Squibb Co. Earnings Analysis: By the Numbers Jul 29 2015
Under the radar names you're missing Jul 28 2015
NantKwest Surges As Biggest Biotech Market Cap IPO Jul 28 2015
Wait, Will Allergan Really Buy Biogen or Amgen? Jul 28 2015
Celgene Corporation Commences Tender Offer for Receptos, Inc. Jul 28 2015
Celgene Corporation Commences Tender Offer for Receptos, Inc. Jul 28 2015
CELGENE CORP /DE/ Files SEC form 8-K, Other Events, Financial Statements and Exhibits Jul 28 2015
Gilead Earnings Preview and The Moment of Truth Jul 27 2015
Morgan Stanley Raises Price Target On Celgene, Still Highlights Several Risks Jul 27 2015
Biogen: Buy the Stock Get the Pipeline for Free Jul 27 2015
Cramer's Stop Trading: Biogen & GrubHub Jul 27 2015
Short Sellers Back Off Major Biotechs Jul 27 2015
Celgene to acquire Receptos, advancing leadership in immune-inflammatory diseases Jul 27 2015


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK